ReviewCurrent cardiology reports2022
SGLT2 Inhibitors: Benefits for CKD and Cardiovascular Disease in Type 2 Diabetes.
Rohit Singhal et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this paperpooled itcites it
ReviewCurrent cardiology reports2022
Rohit Singhal et al.PubMed ↗Publisher ↗
No numbers read from the abstract.